| Summary of net revenue by product category |
The following table summarizes net revenue by product category for the three and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Diabetes | | $ | 198,820 | | $ | 191,056 | | $ | 384,606 | | $ | 378,416 | Sleep therapy | | | 148,575 | | | 181,622 | | | 315,497 | | | 363,481 | Home respiratory therapy | | | 90,996 | | | 109,526 | | | 188,175 | | | 218,132 | Ostomy | | | 55,675 | | | 51,893 | | | 107,011 | | | 101,392 | Wound care | | | 40,193 | | | 46,822 | | | 79,595 | | | 93,468 | Urology | | | 31,295 | | | 28,696 | | | 61,085 | | | 56,839 | Other | | | 47,680 | | | 72,302 | | | 105,045 | | | 144,073 | Net revenue | | $ | 613,234 | | $ | 681,917 | | $ | 1,241,014 | | $ | 1,355,801 |
The following table summarizes net revenue by payor type for the three and six months ended June 30, 2026 and 2025: | | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Commercial payors (1) | | $ | 478,207 | | $ | 550,828 | | $ | 971,412 | | $ | 1,094,356 | Medicare | | | 128,206 | | | 121,724 | | | 253,922 | | | 242,054 | Medicaid | | | 6,821 | | | 9,365 | | | 15,680 | | | 19,391 | Net revenue | | $ | 613,234 | | $ | 681,917 | | $ | 1,241,014 | | $ | 1,355,801 |
(1) Commercial payors includes revenue from Medicare Advantage plans.
|
| Summary of cost of revenue |
| | | | | | | | | | | | | | | Three Months Ended | | Six Months Ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | Cost of products sold | | $ | 311,511 | | $ | 319,517 | | $ | 626,903 | | $ | 636,906 | Patient service equipment depreciation | | | 32,995 | | | 31,883 | | | 61,884 | | | 63,566 | Other costs | | | 5,321 | | | 5,915 | | | 10,792 | | | 11,485 | Cost of net revenue | | $ | 349,827 | | $ | 357,315 | | $ | 699,579 | | $ | 711,957 |
|